Biosplice Therapeutics
biosplice.comGood
1
Good
1
68
68
Feb 25, 2026
Biosplice Therapeutics is a biotechnology company known for developing therapies targeting alternative splicing mechanisms, particularly through CLK and DYRK kinase inhibitors, with applications in diseases like osteoarthritis, Alzheimer's, and cancer. Its AI visibility is moderate, as it is recognized in specialized biotech contexts but lacks broad public awareness. Content coverage includes scientific literature and industry news, though sentiment is mixed due to past controversies and clinical challenges. Overall, AI systems can provide accurate information but may not rank it highly for general user queries.
How well AI models identify your brand
How accurately AI describes your business
How thoroughly AI covers your offerings
How positively AI portrays your brand
| Date | Score | Rating | View |
|---|---|---|---|
Feb 25, 2026Multi-Model | 68 | Good | View Details |
Run a comprehensive AI Brand Audit to get actionable recommendations.